What challenges do you see with your asthma patients? This was the subject of Dr Lily Higgins’ session at the American Lung Association’s LUNGFORCE Expo 2019. See what challenges were discussed here.
After a clinical trial demonstrated its efficacy, the FDA approved a new treatment option for adult and pediatric patients with a rare, inherited metabolic disorder.
The US Food and Drug Administration recently approved the first pill with an embedded digital ingestion tracking system for patients with schizophrenia, bipolar disorder, and depression.
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
Antithrombotic medications are some of the most commonly prescribed medications. In a recent study, researchers investigated whether use of these drugs was associated with increased risk of...
The ideal timing of renal replacement therapy in critically ill patients with acute kidney injury remains unclear, despite extensive previous studies. In a recent meta-analysis, researchers sought to...
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
A recent meta-analysis sought to address this gap by examining studies that assessed the safety and efficacy of SSRIs and SNRIs in children with various psychiatric disorders.
